Welcome to our dedicated page for Elbit Sys SEC filings (Ticker: ESLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Elbit Systems Ltd (ESLT) SEC filings page provides access to the company’s U.S. regulatory disclosures as a foreign private issuer. Elbit Systems files an annual report on Form 20-F and current reports on Form 6-K under the Securities Exchange Act of 1934. These filings furnish information such as press releases, financial results, contract announcements, proxy materials and other corporate updates for investors who follow ESLT stock.
Form 6-K reports from Elbit Systems typically attach press releases covering topics like quarterly and semi-annual financial results, order backlog, major defense contracts, capital-raising transactions, rating agency reports, shelf prospectus developments in Israel and outcomes of annual general meetings of shareholders. For example, recent 6-K filings have furnished releases on second and third quarter 2025 results, large international contracts, tank upgrade programs, rocket artillery systems, and the extension of the company’s shelf prospectus in Israel.
Form 20-F, which is referenced in the company’s press releases, contains more comprehensive annual information, including audited financial statements, risk factors, a description of business segments and details on corporate governance. Together, these filings help explain how Elbit Systems presents its financial condition, results of operations, order backlog, funding activities and governance framework to U.S. regulators and investors.
On this page, users can review ESLT 6-K current reports, the latest 20-F annual report and related documents as they become available from EDGAR. AI-powered tools on the platform can assist by summarizing lengthy filings, highlighting key sections on topics such as revenue by segment, order backlog, capital structure and risk disclosures, and helping readers quickly locate information relevant to their analysis of Elbit Systems Ltd.
Elbit Systems Ltd. reported a major new defense win, securing a contract worth approximately $750 million (€650 million) to supply its PULS rocket artillery systems to the Hellenic Armed Forces. The deal is part of an agreement between the Israeli and Hellenic defense ministries.
The contract will be executed over 4 years and followed by an additional ten-year support period. It covers PULS launchers and a broad munitions package, including training rockets, precision‑guided rockets for various ranges and loitering munitions. Elbit Systems will work with Greek industries on production, including technology transfer and know‑how sharing.
The company describes PULS as a flexible, cost‑effective artillery solution adaptable to wheeled and tracked platforms. Elbit Systems, which reported $7,938.6 million in revenues and an $28.1 billion order backlog for the year ended December 31, 2025, views this contract as further strengthening its long‑standing relationship with Greece and adding to its European customer base.
Elbit Systems Ltd Executive Vice President Haim Daniel Delmar received an award of 5,000 employee stock options, indirectly held in an employee benefit trust managed by IBI Trust Management. The options have an exercise price of 912.6000 per share and are exercisable into 5,000 Ordinary Shares.
The options vest in three tranches: 40% on March 24, 2028, 30% on March 24, 2029, and 30% on March 24, 2030, and expire on June 24, 2031. The plan uses a net exercise mechanism, so the actual shares delivered upon exercise will likely be fewer than 5,000. Mr. Delmar is the sole beneficiary of the options.
Elbit Systems Ltd Executive Vice President Ariel Jonathan has filed an initial ownership report showing indirect holdings of employee stock options held in an employee benefit trust managed by IBI Trust Management. These options relate to ordinary shares of Elbit Systems.
The filing lists options over 9,000 underlying shares at an exercise price of 134.3400 per share expiring on July 7, 2027, and options over 40,000 underlying shares at 197.8200 per share expiring on December 19, 2028. Footnotes explain that the 2021 grant is largely vested, the remainder vesting on April 7, 2026, while the 2024 grant vests in stages from September 19, 2026 through September 19, 2028, and that a net exercise mechanism will generally reduce the number of shares actually received upon exercise.
Elbit Systems Ltd Executive Vice President Haim Daniel Delmar reports existing stock option holdings. The Form 3 shows indirect beneficial ownership of employee stock options over 9,000 ordinary shares at an exercise price of $134.34 expiring on July 7, 2027, and 40,000 shares at $197.82 expiring on December 19, 2028. These options were granted in 2021 and 2024 with vesting schedules through April 7, 2026 and from September 19, 2026 to September 19, 2028, and are subject to a net exercise mechanism that typically delivers fewer shares than the underlying option amount.
Elbit Systems Ltd Executive Vice President Oren Yaacov Sabag filed an initial ownership report showing indirect holdings of employee stock options held in an employee benefit trust managed by IBI Trust Management.
He holds options over 10,000 ordinary shares with an exercise price of $134.34 expiring on July 7, 2027, and options over 45,000 ordinary shares with an exercise price of $197.82 expiring on December 19, 2028.
Footnotes explain that a 2021 option grant is 80% vested, with the remaining 20% vesting on April 7, 2026, and that exercises use a net exercise mechanism so the actual shares received will be fewer than the underlying amounts. A 2024 grant vests in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028. Mr. Sabag is the sole beneficiary of these options.
Elbit Systems Ltd. executive Ran Kril, an Executive Vice President, reported his initial beneficial ownership of two indirect employee stock option grants over the company’s ordinary shares. The options are held in an employee benefit trust managed by IBI Trust Management, with Mr. Kril as the sole beneficiary.
One option grant covers 8,000 underlying ordinary shares at an exercise price of 134.3400 per share and expires on July 7, 2027. The other covers 50,000 underlying ordinary shares at an exercise price of 197.8200 per share and expires on December 19, 2028. A net exercise mechanism may result in fewer shares being issued upon exercise.
The filing notes that the April 7, 2021 grant is 80% vested, with the remaining 20% vesting on April 7, 2026, while the September 19, 2024 grant vests in three tranches through September 19, 2028.
Elbit Systems Ltd Executive Vice President Vered Yehuda filed an initial ownership report showing indirect employee stock option holdings. The filing lists options over 9,000 ordinary shares at an exercise price of 134.3400 per share expiring on July 7, 2027, and options over 50,000 ordinary shares at an exercise price of 197.8200 per share expiring on December 19, 2028.
The 2021 grant is 80% vested, with the remaining 20% vesting on April 7, 2026. The 2024 grant vests in tranches from 2026 to 2028. All options are held in an employee benefit trust, with Yehuda as sole beneficiary, and use a net exercise mechanism, so the shares ultimately received will be fewer than the underlying option amounts.
ELBIT SYSTEMS LTD Executive Vice President and CFO Dr. Yaacov Shimon Kagan reported his existing employee stock option holdings. He holds options, indirectly through an employee benefit trust, over 12,000 underlying ordinary shares at an exercise price of 216.5300 per share expiring on December 14, 2027, and options over 60,000 underlying ordinary shares at 197.8200 per share expiring on December 19, 2028.
Footnotes explain that a net exercise mechanism applies, so the number of shares actually received upon exercise will reflect only the value above the exercise price and will likely be fewer than the total optioned shares. The options vest in tranches between September 2026 and September 2028, and are held in trust for Dr. Kagan as sole beneficiary.
Elbit Systems Ltd filed an initial insider report showing President and CEO Bezhalel Machlis’s employee stock options held in trust. These options give an indirect right to acquire 30,000 ordinary shares at an exercise price of 134.3400 per share, expiring on July 7, 2027, and 400,000 ordinary shares at 197.8200 per share, expiring on December 19, 2028.
The options are held in an employee benefit trust managed by IBI Trust Management, with Mr. Machlis as sole beneficiary. Footnotes explain that an April 7, 2021 grant is 80% vested, with the remaining 20% vesting on April 7, 2026, and a September 19, 2024 grant vests in tranches through September 19, 2028. A net exercise mechanism means the actual shares received upon exercise will be fewer than the options’ underlying share counts.
Elbit Systems Ltd Executive Vice President Yoram Shmuely has filed an initial statement of holdings showing both options and shares in the company. He holds employee stock options held in an employee benefit trust by IBI Trust Management over 9,000 underlying ordinary shares at an exercise price of 134.34 and 50,000 underlying ordinary shares at an exercise price of 197.82, expiring in 2027 and 2028. Footnotes explain that the 2021 option grant is mostly vested, with the remainder vesting in 2026, and that the 2024 grant vests in stages from 2026 to 2028. A net exercise mechanism means the actual shares received on exercise will likely be fewer than the optioned amounts. He also directly owns 50 ordinary shares.